Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma

Journal of Molecular Histology

Volumn 47, Issue 2, 2016, Pages 105-116

  Wang, Qiang ^a   Wang, Xiaoying ^b   Tian, Xiufen ^b   Tang, Ronghua ^b   Xu, Xin ^b  

^a JINAN STOMATOLOGICAL HOSPITAL   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Four and a half LIM domains 2; Tongue squamous cell carcinoma; Transcriptional cofactor

Indexed keywords

BETA CATENIN; CELL PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIM PROTEIN; RNA; FHL2 PROTEIN, HUMAN; LIM HOMEODOMAIN PROTEIN; MESSENGER RNA; MUSCLE PROTEIN; TRANSCRIPTION FACTOR;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL CYCLE; CELL GROWTH; CELL INVASION ASSAY; CELL MIGRATION ASSAY; CLINICAL ARTICLE; DNA CONTENT; FLOW CYTOMETRY; FOUR AND A HALF LIM DOMAINS 2; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TONGUE CARCINOMA; WESTERN BLOTTING; ANIMAL; CELL MOTION; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROTEIN SYNTHESIS; SQUAMOUS CELL CARCINOMA; TONGUE TUMOR; TUMOR CELL LINE; TUMOR INVASION; UPREGULATION;

ANIMALS; BETA CATENIN; CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIM-HOMEODOMAIN PROTEINS; MALE; MICE, NUDE; MIDDLE AGED; MUSCLE PROTEINS; NEOPLASM INVASIVENESS; NF-KAPPA B; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; TONGUE NEOPLASMS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; UP-REGULATION;

EID: 84954327638     PISSN: 15672379     EISSN: 15672387     Source Type: Journal    
DOI: 10.1007/s10735-016-9654-7     Document Type: Article

References (33)

1. Amann T, Egle Y, Bosserhoff AK, Hellerbrand C (2010) FHL2 suppresses growth and differentiation of the colon cancer cell line HT-29. Oncol Rep 23:1669–1674
2. Brun J, Dieudonne FX, Marty C, Muller J, Schule R, Patino-Garcia A, Lecanda F, Fromigue O, Marie PJ (2013) FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo. PLoS One 8:e55034
3. Cao CY, Mok SW, Cheng VW, Tsui SK (2015) The FHL2 regulation in the transcriptional circuitry of human cancers. Gene 572:1–7
4. Chen YH, Wu ZQ, Zhao YL, Si YL, Guo MZ, Han WD (2012) FHL2 inhibits the Id3-promoted proliferation and invasive growth of human MCF-7 breast cancer cells. Chin Med J (Engl) 125:2329–2333
5. Duan L, Yao J, Wu X, Fan M (2006) Growth suppression induced by Notch1 activation involves Wnt–β-catenin down-regulation in human tongue carcinoma cells. Biol Cell 98:479–490
6. Fujii M, Katase N, Lefeuvre M, Gunduz M, Buery RR, Tamamura R, Tsujigiwa H, Nagatsuka H (2011) Dickkopf (Dkk)-3 and β-catenin expressions increased in the transition from normal oral mucosal to oral squamous cell carcinoma. J Mol Histol 42:499–504
7. Genini MSP, Scholl FA, Remppis A, Mattei MG, Schäfer BW (1997) Subtractive cloning and characterization of DRAL, a novel LIM-domain protein down-regulated in rhabdomyosarcoma. DNA Cell Biol 16:433–442
8. He KF, Zhang L, Huang CF, Ma SR, Wang YF, Wang WM, Zhao ZL, Liu B, Zhao YF, Zhang WF, Sun ZJ (2014) CD163+ tumor-associated macrophages correlated with poor prognosis and cancer stem cells in oral squamous cell carcinoma. Biomed Res Int 2014:838632
9. Hu FW, Lee SS, Yang LC, Tsai CH, Wang TH, Chou MY, Yu CC (2015) Knockdown of S100A4 impairs arecoline-induced invasiveness of oral squamous cell carcinomas. Oral Oncol 51:690–697
10. Huang CF, Yu GT, Wang WM, Liu B, Sun ZJ (2014) Prognostic and predictive values of SPP1, PAI and caveolin-1 in patients with oral squamous cell carcinoma. Int J Clin Exp Pathol 7:6032–6039
11. Jia LF, Wei SB, Gan YH, Guo Y, Gong K, Mitchelson K, Cheng J, Yu GY (2013) Expression, regulation and roles of MiR-26a and MEG3 in tongue squamous cell carcinoma. Int J Cancer 135:2282–2293
12. Kleiber K, Strebhardt K, Martin BT (2007) The biological relevance of FHL2 in tumour cells and its role as a putative cancer target. Anticancer Res 27:55–61
13. Kurakula K, van der Wal E, Geerts D, van Tiel CM, de Vries CJ (2011) FHL2 protein is a novel co-repressor of nuclear receptor Nur77. J Biol Chem 286:44336–44343
14. Lai CF, Bai S, Uthgenannt BA, Halstead LR, McLoughlin P, Schafer BW, Chu PH, Chen J, Otey CA, Cao X, Cheng SL (2006) Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation. J Bone Miner Res 21:17–28
15. Lee SH, Koo BS, Kim JM, Huang S, Rho YS, Bae WJ, Kang HJ, Kim YS, Moon JH, Lim YC (2014) Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4. J Pathol 234:99–107
16. Lim W, Choi H, Kim J, Kim S, Jeon S, Ni K, Song SY, Oh HK, Im Y, Lee G, Lee JY, Moon YL, You JW, Kim O (2014) Expression of cancer stem cell marker during 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. J Mol Histol 45:653–663
17. Martin B, Schneider R, Janetzky S, Waibler Z, Pandur P, Kuhl M, Behrens J, von der Mark K, Starzinski-Powitz A, Wixler V (2002) The LIM-only protein FHL2 interacts with β-catenin and promotes differentiation of mouse myoblasts. J Cell Biol 159:113–122
18. Mignogna MD, Fedele S, Lo Russo L (2004) The World Cancer Report and the burden of oral cancer. Eur J Cancer Prev 13:139–142
19. Ng CF, Ng PK, Lui VW, Li J, Chan JY, Fung KP, Ng YK, Lai PB, Tsui SK (2011) FHL2 exhibits anti-proliferative and anti-apoptotic activities in liver cancer cells. Cancer Lett 304:97–106
20. Qiao L, Wang Y, Pang R, Wang J, Dai Y, Ma J, Gu Q, Li Z, Zhang Y, Zou B, Lan HY, Wong BC (2009) Oncogene functions of FHL2 are independent from NF-κBIα in gastrointestinal cancer. Pathol Oncol Res 15:31–36
21. Tian X, Wang Q, Wang X (2015) Four and a half LIM domain protein 2 enhances differentiation and mineralization of human dental pulp cells. J Endod 41:513–519
22. Wang J, Yang Y, Xia HH, Gu Q, Lin MC, Jiang B, Peng Y, Li G, An X, Zhang Y, Zhuang Z, Zhang Z, Kung HF, Wong BC (2007) Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis. Gastroenterology 132:1066–1076
23. Wei Y, Renard CA, Labalette C, Wu Y, Levy L, Neuveut C, Prieur X, Flajolet M, Prigent S, Buendia MA (2003) Identification of the LIM protein FHL2 as a coactivator of β-catenin. J Biol Chem 278:5188–5194
24. Wu T, Jia J, Xiong X, He H, Bu L, Zhao Z, Huang CF, Zhang WF (2013a) Increased expression of Lin28B associates with poor prognosis in patients with oral squamous cell carcinoma. PLoS One 8:e83869
25. Wu X, Cao W, Wang X, Zhang J, Lv Z, Qin X, Wu Y, Chen W (2013b) TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer. Mol Cancer 12:151
26. Xia J, Wang J, Chen N, Dai Y, Hong Y, Chen X, Cheng B (2011) Expressions of CXCR7/ligands may be involved in oral carcinogenesis. J Mol Histol 42:175–180
27. Xia T, Levy L, Levillayer F, Jia B, Li G, Neuveut C, Buendia MA, Lan K, Wei Y (2013) The four and a half LIM-only protein 2 (FHL2) activates transforming growth factor β (TGF-β) signaling by regulating ubiquitination of the E3 ligase Arkadia. J Biol Chem 288:1785–1794
28. Yao J, Duan L, Fan M, Yuan J, Wu X (2007) Overexpression of BLCAP induces S phase arrest and apoptosis independent of p53 and NF-κB in human tongue carcinoma: BLCAP overexpression induces S phase arrest and apoptosis. Mol Cell Biochem 297:81–92
29. Yu T, Liu K, Wu Y, Fan J, Chen J, Li C, Yang Q, Wang Z (2014) MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway. Oncogene 33:5017–5027
30. Zhang W, Wang J, Zou B, Sardet C, Li J, Lam CS, Ng L, Pang R, Hung IF, Tan VP, Jiang B, Wong BC (2011) Four and a half LIM protein 2 (FHL2) negatively regulates the transcription of E-cadherin through interaction with Snail1. Eur J Cancer 47:121–130
31. Zhang L, Zhang W, Wang YF, Liu B, Zhang WF, Zhao YF, Kulkarni AB, Sun ZJ (2015) Dual induction of apoptotic and autophagic cell death by targeting survivin in head neck squamous cell carcinoma. Cell Death Dis 6:e1771
32. Zhu Z, Xu X, Yu Y, Graham M, Prince ME, Carey TE, Sun D (2010) Silencing heat shock protein 27 decreases metastatic behavior of human head and neck squamous cell cancer cells in vitro. Mol Pharm 7:1283–1290
33. Zienert E, Eke I, Aust D, Cordes N (2015) LIM-only protein FHL2 critically determines survival and radioresistance of pancreatic cancer cells. Cancer Lett 364:17–24